Brief: Solara Active Pharma Sciences Seeks Shareholders' Nod To Up Value Of Deals With Strides Pharma Science For FY 2018-19
Feb 25 (Reuters) - Solara Active Pharma Sciences Ltd
SOLA.NS :
* SEEKS SHAREHOLDERS' NOD TO INCREASE VALUE OF TRANSACTIONS
WITH
STRIDES PHARMA SCIENCE FOR FY 2018-19 TO 4 BILLION RUPEES
Source text: http://bit.ly/2T3aqmP
Further company coverage: SOLA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solara Active Pharma Sciences
See all newsIndia's Solara Active Pharma Sciences rises after quarterly profit
Brief: Solara Active Pharma Sciences Says Sept-Quarter Consol Net Profit 284.6 Million Rupees
Brief: Solara Active Pharma Sciences Says Tax Demand Of 1.62 Billion Rupees Reduced To Nil After Rectification
Brief: Solara Active Pharma Sciences June-Quarter Consol Net Profit 163.1 Million Rupees
Brief: Solara Active Pharma Sciences March-Quarter Consol Net Profit 96 Million Rupees